NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
about
Neuregulin and BDNF induce a switch to NMDA receptor-dependent myelination by oligodendrocytesOligodendrocyte genes, white matter tract integrity, and cognition in schizophreniaNeurotransmitter receptors in the life and death of oligodendrocytesThe role of neuronal complexes in human X-linked brain diseasesCurrent Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple SclerosisRodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic ReviewSystematic Review of Pharmacological Properties of the Oligodendrocyte LineageAdaptive myelination from fish to man.The Role of Astrocytes in Multiple Sclerosis ProgressionGlutamatergic Transmission: A Matter of ThreeLactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interactionNeuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serineIonic regulation of cell volume changes and cell death after ischemic stroke.Role of NG2 expressing cells in addiction: a new approach for an old problemGlutamate receptor ion channels: structure, regulation, and functionGlutamate excitotoxicity inflicts paranodal myelin splitting and retractionDual-specific phosphatase-6 (Dusp6) and ERK mediate AMPA receptor-induced oligodendrocyte deathNMDA receptor couples Rac1-GEF Tiam1 to direct oligodendrocyte precursor cell migrationDelayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4Identification of Bax-interacting proteins in oligodendrocyte progenitors during glutamate excitotoxicity and perinatal hypoxia-ischemiaGenetic variation influences glutamate concentrations in brains of patients with multiple sclerosisGenome-wide association study of severity in multiple sclerosis.Oligodendrocytes: biology and pathologyGlutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus.Alteration of synaptic connectivity of oligodendrocyte precursor cells following demyelination.Pathophysiology of glia in perinatal white matter injury.Comparative analysis of putative pathogenesis-related gene expression in two Rhizoctonia solani pathosystems.White matter injury in ischemic stroke.Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptorsThe encephalopathy of prematurity--brain injury and impaired brain development inextricably intertwined.NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionWallerian-like axonal degeneration in the optic nerve after excitotoxic retinal insult: an ultrastructural study.Excitability and synaptic communication within the oligodendrocyte lineageHDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammationWhite matter loss in a mouse model of periventricular leukomalacia is rescued by trophic factorsMK801 attenuates secondary injury in a mouse experimental compression model of spinal cord trauma.Influence of the NR3A subunit on NMDA receptor functions.
P2860
Q21145719-33CB4F3C-1575-42F1-A97D-53CD083AC1F2Q24289198-896568A0-314F-4428-991E-04C4C07ED376Q24671657-45B1F03C-F3FA-42E6-B639-9B4026F7D268Q24680472-F4BCDC24-676B-49D1-87C4-3C3473631FFAQ26740330-9015061A-B39A-4B60-BDC5-C956A2ECD0D0Q26747485-DF13D87D-3E00-4777-AA8C-F5B9AD2E0121Q26768210-AAFEE860-9A3C-4902-A8C3-B63DAE30B976Q26779643-3B2010C0-FC99-4A8C-8788-BF0C59EAD1ADQ26782843-8BFCEA31-B01B-462B-BF2F-7DF87E5A4AE4Q26783363-7413BD9A-02E1-4F6A-AB7B-8C076946F11FQ26851808-C7361164-559D-42EC-A24C-83FE1767B6E0Q27024914-EE792F16-08AB-422A-932A-3078EDC655C3Q27691821-EB85D774-2497-442B-87C2-F41480BDFC68Q28082885-263B5DB8-28EC-419D-9FA8-FAADA47C90DBQ28290774-30388CCF-B33C-459B-82E2-68D3D354FF15Q28475977-6AC8FF1A-4425-4AAD-BEE7-3EB47C98EAC8Q28566860-2A633643-278D-4C07-97AC-DF5BCB0BD889Q28580426-AD846165-0FE3-48E7-917C-649FB7E7BEB4Q28582010-37EAC5EF-2E2A-4B94-B082-D82043D9BCD5Q28771339-BF9A9961-9EFB-4B80-93E2-0B344E1E6035Q28943414-A4CA7A84-8978-4950-9FEB-2082CD73EF4AQ29417054-0A5E6D22-FBAF-4D45-81C1-CFCBD7D95060Q30051584-14B13E7E-FC50-4CCA-AF84-44FF0B8FC891Q30387014-468EAF23-A485-4F98-BE2C-4EC5378307D4Q30388470-DD9C11A0-8916-4251-BE3A-FF83CCB04A52Q30485404-50455B96-3BB4-4475-8584-F2EB885C8250Q30628440-9527108D-8D71-49F8-8FB3-8938F3DB5675Q30790294-376A7EA3-03F0-4EF4-BC55-04FFEE0C13DAQ31030811-0DA1F99C-A2A0-4FC5-BB3B-80624399F8DEQ31080285-BD02C993-2108-4E32-8DBF-6081D829A3C8Q33410173-75FD9603-14A9-49E3-A36B-5AF862B62030Q33516828-859130D2-B248-416D-8D73-A204D205F5A8Q33565598-1DD2AFD2-6728-4C76-B53B-280BF53D7184Q33626978-F6F5DD95-C45E-4489-8B8D-44B2494CBA52Q33657315-ADBB8DE1-4170-47ED-9187-4BF3C8386E42Q33725968-073C0868-A8CD-43C0-AB68-8C93E2EEDBD7Q33757971-C23A8B10-79FB-4E11-82DB-98C3FF3D2D58Q33772241-426796DB-1566-4318-935B-705E091026A2Q33872820-C8ED7C64-7806-442F-9F31-1EF88DD86A8BQ33906149-7999CF51-0467-4BB4-8247-88A8247C7A69
P2860
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@en
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@nl
type
label
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@en
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@nl
prefLabel
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@en
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@nl
P2860
P356
P1433
P1476
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
@en
P2093
Michael G Salter
Robert Fern
P2860
P2888
P304
P356
10.1038/NATURE04301
P407
P577
2005-12-01T00:00:00Z
P5875
P6179
1009535361